NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
REDRegorafenib 40mg Stivarga®
(Tablets) 		Malignant disease and immunosuppression, Protein kinase inhibitors, 08.01.05
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Regorafenib  Regorafenib [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Protein Kinase Inhibitors
Targeted Therapy Responsive Malignancy
Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.
Links found
NICE TA488:Regorafenib for previously treated unresectable or metastatic gastrointestinal stromal tumours
NICE TA514: Regorafenib for previously treated advanced hepatocellular carcinoma
NICE TA555: Regorafenib for previously treated advanced hepatocellular carcinoma
NICE TA866: Regorafenib for previously treated metastatic colorectal cancer